Nystatin (Fungicidin): Polyene Antifungal Agent for Candida and Fungal Cell Membrane Research

Executive Summary: Nystatin (Fungicidin) is a polyene antifungal agent that exerts its effect by binding ergosterol in fungal cell membranes, leading to membrane disruption and cell death (APExBIO). It exhibits potent inhibitory activity against multiple Candida species, with MIC₉₀ values for Candida albicans around 4 mg/L, and effective ranges for non-albicans Candida from 0.39 to 3.12 μg/mL (vx-661.com). Liposomal formulations protect neutropenic mice from Aspergillus infection at doses as low as 2 mg/kg/day. Nystatin is insoluble in water and ethanol but soluble in DMSO at ≥30.45 mg/mL. Disruption of cellular cholesterol by nystatin does not inhibit Spiroplasma eriocheiris entry into Drosophila S2 cells (Wei et al., 2019).

Biological Rationale

Nystatin (Fungicidin), a polyene antifungal antibiotic, is a standard tool for probing fungal cell membrane integrity and antifungal susceptibility in research. The compound is highly active against a range of pathogenic yeasts, particularly Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida krusei (APExBIO). Its selectivity arises from its high affinity for ergosterol, a fungal-specific sterol absent in mammalian cell membranes, allowing targeted disruption of fungal cells while sparing host tissues (pha-793887.com). Nystatin is widely adopted in experimental models of vulvovaginal candidiasis, antifungal resistance, and fungal adhesion studies. Notably, it does not inhibit certain bacterial infections in invertebrate cell models, as shown for Spiroplasma eriocheiris in Drosophila S2 cells (Wei et al., 2019), clarifying its antifungal selectivity.

Mechanism of Action of Nystatin (Fungicidin)

Nystatin acts by binding ergosterol within the fungal cell membrane. This binding induces the formation of pores, resulting in increased membrane permeability. The resultant leakage of essential ions and metabolites leads to cell death (vx-661.com). The mechanism is highly specific to fungi due to the presence of ergosterol, rather than cholesterol, in their membranes. In mammalian cells, which lack ergosterol, nystatin shows minimal activity at therapeutic concentrations. This selectivity underpins its widespread research and clinical utility as an antifungal agent. Notably, nystatin disruption of cholesterol-rich domains does not block certain endocytic pathways, as evidenced in insect cell infection models (Wei et al., 2019).

Evidence & Benchmarks

• Nystatin exhibits a MIC₉₀ of ~4 mg/L for C. albicans in standard antifungal susceptibility tests (APExBIO).
• Effective inhibitory concentrations span 0.39–3.12 μg/mL for non-albicans Candida species under laboratory conditions (vx-661.com).
• Liposomal nystatin at 2 mg/kg/day protects neutropenic mice against Aspergillus infection in preclinical models (n3-kethoxal.com).
• Nystatin reduces adhesion of Candida species to human buccal epithelial cells; the adhesion of C. albicans is less affected compared to non-albicans species (pq401.com).
• Nystatin does not inhibit entry of Spiroplasma eriocheiris into Drosophila S2 cells, demonstrating its lack of effect on caveola-mediated endocytosis in invertebrate models (Wei et al., 2019).

Applications, Limits & Misconceptions

Nystatin (Fungicidin) has broad applications in research, including:

• Antifungal susceptibility testing for Candida and Aspergillus species.
• Dissecting ergosterol-mediated fungal cell membrane biology.
• Evaluating antifungal resistance, especially in non-albicans Candida (vx-661.com; this article provides updated benchmarks for resistance models versus the earlier protocol-focused review).
• Studying inhibition of fungal adhesion to mammalian epithelial cells.

However, it is ineffective for treating or modeling bacterial, viral, or non-fungal eukaryotic infections. For example, nystatin did not inhibit Spiroplasma eriocheiris entry into insect cells, clarifying its mechanistic specificity (Wei et al., 2019).

Common Pitfalls or Misconceptions

• Not effective for bacteria or viruses: Nystatin is inactive against bacteria, including mycoplasmas, and all viruses (Wei et al., 2019).
• Does not block caveola-mediated endocytosis in invertebrate cells: Nystatin fails to inhibit caveolae-dependent entry of pathogens like Spiroplasma eriocheiris in Drosophila S2 cells.
• Limited solubility: It is insoluble in water and ethanol, requiring DMSO for stock solutions (≥30.45 mg/mL).
• Short-term solution stability: Nystatin solutions are not suitable for long-term storage; use promptly after preparation, and store below -20°C.
• Not suitable for all fungal species: Some filamentous fungi may exhibit intrinsic resistance or require higher concentrations for inhibition.

Workflow Integration & Parameters

Nystatin (Fungicidin) from APExBIO (SKU: B1993) is supplied as a solid, with a molecular weight of 926.09 and chemical formula C₄₇H₇₅NO₁₇ (product page). For use, dissolve in DMSO to reach concentrations of at least 30.45 mg/mL. Warming and ultrasonic shaking can enhance solubility. Stock solutions should be stored below -20°C and are stable for several months. Nystatin is insoluble in water and ethanol. For antifungal assays, working concentrations should be selected based on MIC data for the target species (e.g., 0.39–4 mg/L for Candida spp.). Solutions are not recommended for long-term storage; prepare fresh aliquots as needed. For studies on fungal adhesion, pre-treatment of host cells or fungal cells with nystatin can be performed at benchmarked concentrations. Liposomal formulations are required for systemic use in animal infection models.

For a detailed protocol on antifungal workflows and troubleshooting, see this advanced guide (which this article extends by providing comparative resistance and adhesion data).

For an in-depth review of membrane biology and ergosterol targeting, see this article (this dossier further clarifies the selectivity of nystatin in non-fungal systems).

Conclusion & Outlook

Nystatin (Fungicidin) is a validated, potent polyene antifungal agent for dissecting fungal membrane biology, antifungal resistance, and host-pathogen interactions in research. Its specificity for ergosterol enables selective targeting of fungal pathogens while sparing mammalian cells. Limitations include solubility constraints and ineffectiveness against non-fungal organisms or caveolae-mediated endocytosis in invertebrate models. Continued benchmarking and protocol refinement will further support its role in antifungal discovery and translational studies. For reagent details and ordering, consult the Nystatin (Fungicidin) product page from APExBIO.